Trial
NCT02601365
Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Acute Respiratory Distress Syndrome
Intervention
Sargramostim 0.04 mcg/kg/dose
Why stopped
Clinical Hold FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-02